N-(1-(3-acrylamidophenylsulfonyl)piperidin-4-yl)-4-(2,6-dichloro-3-methoxybenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate

ID: ALA4563703

PubChem CID: 155559296

Max Phase: Preclinical

Molecular Formula: C28H27Cl2F3N6O8S

Molecular Weight: 621.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)ccc(OC)c3Cl)CC2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C26H26Cl2N6O6S.C2HF3O2/c1-3-21(35)30-16-5-4-6-17(13-16)41(38,39)34-11-9-15(10-12-34)31-26(37)24-19(14-29-33-24)32-25(36)22-18(27)7-8-20(40-2)23(22)28;3-2(4,5)1(6)7/h3-8,13-15H,1,9-12H2,2H3,(H,29,33)(H,30,35)(H,31,37)(H,32,36);(H,6,7)

Standard InChI Key:  QPIWFKYDGXVUCG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 48 50  0  0  0  0  0  0  0  0999 V2000
   12.1222  -14.3254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8299  -13.9168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4145  -13.9168    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.1222  -15.1426    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.4123  -14.7298    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.5376  -14.3254    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8299  -13.0996    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0852  -15.9105    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0894  -15.0933    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.3796  -15.4983    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1945  -12.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0117  -12.2620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7859  -11.5543    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7859  -12.9697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9696  -12.9670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5611  -13.6738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9697  -14.3825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7911  -14.3799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1959  -13.6724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6460  -12.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4202  -11.5565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2375  -11.5543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4880  -10.7764    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8255  -10.2977    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1657  -10.7799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4632  -12.2620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2375  -12.9697    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8718  -12.9697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4621  -13.6754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8673  -14.3810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6848  -14.3852    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0956  -13.6777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6888  -12.9659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9079  -15.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3107  -15.8096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1271  -15.8131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5392  -15.1064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1289  -14.3948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3138  -14.3948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5327  -16.5225    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3499  -16.5260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7555  -17.2354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7615  -15.8200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5727  -17.2389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5623  -12.2585    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.0131  -13.6690    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.2022  -15.0861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7961  -15.7953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  9  8  2  0
 10  9  2  0
 11 12  1  0
 11 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 12 21  1  0
 22 20  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 21  2  0
 20 26  1  0
 20 27  2  0
 26 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 31  9  1  0
  9 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
 36 40  1  0
 40 41  1  0
 41 42  1  0
 41 43  2  0
 42 44  2  0
 15 45  1  0
 19 46  1  0
 18 47  1  0
 47 48  1  0
M  END

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 621.50Molecular Weight (Monoisotopic): 620.1012AlogP: 3.69#Rotatable Bonds: 9
Polar Surface Area: 162.59Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.75CX Basic pKa: 0.01CX LogP: 3.39CX LogD: 3.39
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.27Np Likeness Score: -1.71

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source